ACADIAN ASSET MANAGEMENT LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 104 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$668
-100.0%
23,870
-77.7%
0.00%
-81.2%
Q3 2022$3,008,000
-32.8%
107,173
-16.7%
0.02%
-30.4%
Q2 2022$4,477,000
+13.4%
128,734
+16.9%
0.02%
+43.8%
Q1 2022$3,949,000
+639.5%
110,148
+378.2%
0.02%
+700.0%
Q4 2021$534,000
+52.6%
23,035
+24.5%
0.00%
+100.0%
Q3 2021$350,000
-82.5%
18,502
-81.4%
0.00%
-87.5%
Q2 2021$2,004,000
+767.5%
99,435
+688.0%
0.01%
+700.0%
Q1 2021$231,000
+106.2%
12,619
+127.2%
0.00%
Q4 2020$112,000
-66.2%
5,554
-68.6%
0.00%
-100.0%
Q3 2020$331,000
-48.4%
17,672
-38.3%
0.00%
-66.7%
Q2 2020$642,000
+555.1%
28,635
+464.1%
0.00%
Q4 2019$98,000
-87.6%
5,076
-87.2%
0.00%
-100.0%
Q3 2019$788,000
+795.5%
39,713
+845.5%
0.00%
Q2 2019$88,000
+39.7%
4,200
+31.2%
0.00%
Q4 2018$63,000
-79.1%
3,202
-83.9%
0.00%
-100.0%
Q2 2018$302,000
-90.4%
19,841
-88.2%
0.00%
-92.9%
Q1 2018$3,152,000
-4.3%
168,084
-1.9%
0.01%0.0%
Q4 2017$3,295,000
-5.3%
171,262
-12.1%
0.01%
-6.7%
Q3 2017$3,481,000
-40.7%
194,797
-40.8%
0.02%
-44.4%
Q2 2017$5,872,000
-29.1%
328,807
-42.4%
0.03%
-28.9%
Q1 2017$8,277,000
-70.1%
570,814
-62.0%
0.04%
-71.6%
Q4 2016$27,668,000
-7.3%
1,502,151
-4.6%
0.13%
-9.5%
Q3 2016$29,858,000
+126.3%
1,573,986
+92.3%
0.15%
+120.9%
Q2 2016$13,195,000
+143.1%
818,620
+81.0%
0.07%
+148.1%
Q1 2016$5,428,000
+20.9%
452,371
+43.4%
0.03%
+17.4%
Q4 2015$4,490,000
+1220.6%
315,555
+982.4%
0.02%
+1050.0%
Q3 2015$340,00029,1530.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2017
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders